LINC02631

Across TCGA pan-cancer cohorts, LINC02631 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of LINC02631’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02631 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02631 is over-expressed in tumor, although a few such as KICH and BRCA show the opposite, repressed pattern.

KIRC, CHOL, and KIRP are the cancer types where LINC02631 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02631 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.055	<.001	10	view →
CHOL	All	II,III,IV	+0.275	<.001	4	view →
KIRP	Female	II,III,IV	+0.114	.012	4	view →
KICH	All	IV	−0.097	<.001	4	view →
STAD	Female	All	+0.257	.029	3	view →
LIHC	All	II,III,IV	+0.092	.010	3	view →
BRCA	All	IV	−0.555	.038	2	view →
LUAD	Male	III,IV	−0.203	.041	1	view →
HNSC	All	All	+0.069	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

LINC02631–KIRC

Open the KIRC breakdown →